BIOMAT Database Logo BIOMAT Database Logo

Reversible, enzyme-activated monoamine oxidase inhibitors: new advances. 1988

M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Pharmaceutical Research Dept., F. Hoffmann-La Roche & Co. Ltd., Basle, Switzerland.

UI MeSH Term Description Entries
D008297 Male Males
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010624 Phenelzine One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC. Fenelzin,2-Phenethylhydrazine,Nardelzine,Nardil,Phenelzine Sulfate,Phenethylhydrazine,beta-Phenylethylhydrazine,2 Phenethylhydrazine,Sulfate, Phenelzine,beta Phenylethylhydrazine
D010848 Picolinic Acids Compounds with general formula C5H4N(CO2H) derived from PYRIDINE, having a carboxylic acid substituent at the 2-position. Acids, Picolinic
D010880 Piperidines A family of hexahydropyridines.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003010 Clorgyline An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Clorgilin,Chlorgyline,Clorgiline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001549 Benzamides BENZOIC ACID amides.

Related Publications

M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Depression and reversible monoamine oxidase inhibitors--new perspectives.
October 1989, The British journal of psychiatry. Supplement,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Monoamine oxidase inhibitors: reversible and irreversible.
January 1992, Psychopharmacology bulletin,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.
February 1985, Journal of medicinal chemistry,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
The pharmacology of reversible monoamine oxidase inhibitors.
October 1989, The British journal of psychiatry. Supplement,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
June 1992, The Australian and New Zealand journal of psychiatry,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Studies of selective and reversible monoamine oxidase inhibitors.
July 1984, The Journal of clinical psychiatry,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Drug interactions with reversible monoamine oxidase-A inhibitors.
January 1993, Clinical neuropharmacology,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Reversible monoamine oxidase-A inhibitors in social phobia.
January 1993, Clinical neuropharmacology,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
January 1993, Clinical neuropharmacology,
M Da Prada, and R Kettler, and A M Cesura, and J G Richards
Reversible monoamine oxidase-A inhibitors in panic disorder.
January 1993, Clinical neuropharmacology,
Copied contents to your clipboard!